StockData
Natera, Inc. logo

Natera, Inc.

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30206% above fair value
$378.92−35.38 (-8.54%)

Close on Nov 2, 2026Market cap $54.62BP/E –Yield –

Natera Operating Lease Cost by Year

Operating Lease Cost ($M) ($M)

Natera Operating Lease Cost: $20.2M in FY2025, up 31.9% from a year earlier.

Latest, FY2025
20.2
Period ended Dec 31, 2025
Change on a year earlier
+31.9%
15.3 in FY2024
History
7 years
Since FY2019
Sources
5
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (2026-02-27) ↗

Reported in Form 10-K/10-Q Note — Leases (XBRL).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOperating Lease Cost ($M) ($M)Year on yearSource
FY2025Dec 31, 202520.2+31.9%Form 10-K (2026-02-27) ↗
FY2024Dec 31, 202415.3+5.5%Form 10-K (2026-02-27) ↗
FY2023Dec 31, 202314.5+5.4%Form 10-K (2026-02-27) ↗
FY2022Dec 31, 202213.8+26.0%Form 10-K (2025-02-28) ↗
FY2021Dec 31, 202110.9+39.6%Form 10-K (2024-02-29) ↗
FY2020Dec 31, 20207.83+1.0%Form 10-K (2023-03-01) ↗
FY2019Dec 31, 20197.75–Form 10-K (2022-02-25) ↗

Cite this data

StockData. (2026). Natera Operating Lease Cost ($M), annual FY2019–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/lease-cost-operating

See every metric in the Natera KPI table. Data updated Nov 2, 2026.